| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |